www.vilyatx.com/Healthcare / BioTech & PharmaFounded: 2022
Vilya is a computational biotechnology company that aims to create medicines that precisely target disease biology through a combination of machine-learning advancements and generative AI. The company uses its proprietary technology platform with a mission to design novel molecular structures with drug-like properties. Vilya’s approach seeks to overcome the limitations of traditional drug discovery methods that rely on random screening tactics. Vilya was founded by Sabah Oney in 2022 and is headquartered in Seattle, WA.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vilya.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.